• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

12.43 -0.17 (-1.39%)
Streaming Delayed Price Updated: 10:44 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 242,584
Open 12.65
Bid (Size) 12.42 (1,100)
Ask (Size) 12.43 (800)
Prev. Close 12.60
Today's Range 12.38 - 12.79
52wk Range 6.685 - 13.01
Shares Outstanding 1,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
December 22, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
1 Small-Cap Stock to Target This Week and 2 That Underwhelm
December 17, 2025
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory

Performance

YTD
N/A
N/A
1 Month
+3.5%
+3.5%
3 Month
+19.5%
+19.5%
6 Month
+47.6%
+47.6%
1 Year
+60.1%
+60.1%

More News

Read More
News headline image
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
December 09, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Via Benzinga
News headline image
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
December 05, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Healthcare Stocks We’re Skeptical Of
December 02, 2025
Via StockStory
Topics Stocks
News headline image
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol
December 02, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal to Participate in Upcoming Investor Conferences
December 02, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
December 01, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? ↗
November 28, 2025
Via The Motley Fool
News headline image
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know
November 21, 2025
Via StockStory
Topics Economy
News headline image
Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs ↗
November 21, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks
November 19, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Russell 2000 Stocks with Warning Signs
November 13, 2025
Via StockStory
News headline image
Amneal Receives U.S. FDA Approval for Iohexol Injection
November 13, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
3 Stocks Under $50 We Steer Clear Of
November 11, 2025
Via StockStory
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
November 11, 2025
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Value Stocks We Find Risky
November 09, 2025
Via StockStory
News headline image
Why Amneal (AMRX) Stock Is Up Today
October 31, 2025
Via StockStory
News headline image
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Q3 2025 Earnings: EPS Beats Estimates, Stock Surges on Raised Guidance ↗
October 30, 2025
Via Chartmill
Topics Earnings
News headline image
Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars
October 30, 2025
Via StockStory
News headline image
Amneal Reports Third Quarter 2025 Financial Results
October 30, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
October 29, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
News headline image
Amneal Earnings: What To Look For From AMRX
October 28, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
October 27, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.43
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 01/02/26 10:44 AM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.43K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 12K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap